Study: Paxlovid lowered COVID hospitalization, death in people more prone to serious disease
By
Kristen Fischer
Oct 03, 2023
As news that COVID-19 activity has declined emerged Monday, a new study was released showing that people vulnerable to severe COVID-19 who took nirmatrelvir and ritonavir (Paxlovid) had a lower risk for...
Paxlovid, Lagevrio lower hospitalization, death risk in people with omicron
By
Kristen Fischer
Sep 22, 2023
People with COVID-19 at risk for severe disease had a lower risk for death and hospitalization if they took nirmatrelvir (Paxlovid) or balapiravir (Lagevrio) compared to no treatment at all, a new study...
FDA grants Paxlovid full approval, says drug remains effective COVID-19 treatment
By
Alicia Lasek
May 26, 2023
Paxlovid, which received emergency use authorization in December of 2021, continues to be an effective treatment for COVID-19, the agency said Thursday.
Resistance to COVID-19 antiviral drugs already evident: study
By
Alicia Lasek
Apr 03, 2023
SARS-CoV-2 variants already are showing mutations that may make them resistant to the COVID-19 pill Paxlovid and at least one other approved antiviral drug, researchers report.
Large EHR study confirms Paxlovid works best within 5-day time window
By
Alicia Lasek
Mar 20, 2023
Protection against severe outcomes soared to 80% when the drug was dispensed within five days of symptom onset, compared with 54% efficacy outside that time frame, investigators found.
FDA advisers support full approval of Paxlovid for at-risk older adults
By
Alicia Lasek
Mar 16, 2023
The antiviral drug Paxlovid should receive full FDA approval to treat COVID-19 in older adults at risk of severe outcomes, the advisers decided in a Thursday vote.
Paxlovid effective against omicron variants, new research finds
By
John Roszkowski
Feb 14, 2023
Researchers from the University of Colorado School of Medicine say the prescription drug Paxlovid remains a very effective treatment against the COVID-19 omicron variants.
FDA no longer requires positive COVID-19 test to prescribe Paxlovid, Lagevrio
By
Alicia Lasek
Feb 01, 2023
The FDA on Wednesday made it easier for clinicians to prescribe these antiviral drugs in cases where transmission is evident and the patient is at high risk of severe illness.
Paxlovid cuts COVID hospitalization, which may leave older adults weakened
By
Alicia Lasek
Dec 02, 2022
The CDC reports that COVID patients treated with the antiviral Paxlovid have a 51% lower risk of hospitalization, while another study has tied acute-care stays to muscle loss and long COVID.
Clinical briefs for Thursday, Dec. 1
By
Alicia Lasek
Dec 01, 2022
Drug overdoses in seniors climb between 2000 and 2020 … Predictive clinical tool determines 5, 9 and 13-year risk of dementia … Remdesivir and corticosteroids tied to better COVID acute-care outcomes...